ࡱ> 140g ' bjbj** BHibHib! 8L X '<dd"W'Y'Y'Y'Y'Y'Y'$)+*}'RRR}'H'   RW' RW'  V)#Y$0ᵟ?+bX# C''0'$T++Y$Y$&+$> , 8$\}'}'R'RRRR+ > : 10A NCAC 41A .0405 EXEMPTION FOR CLINICAL STUDIES An individual enrolled in a clinical trial of the efficacy of a new vaccine preparation or dosage schedule shall be exempted from those requirements of 10A NCAC 41A .0401 and .0402 which conflict with the trial protocol. This exemption shall only apply to individuals who: (1) participate in a clinical trial whose protocol is approved by the State Health Director, and (2) fully participate in and complete the clinical trial. History Note: Authority G.S. 130A152(c); Eff. October 1, 1983; Temporary Amendment Eff. February 1, 1988, for a period of 180 days to expire on July 29, 1988; Amended Eff. March 1, 1988; Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. January 9, 2018.     NUMPAGES1 of      o p             " # $ & ' hcmHnHuhNjhNUhHjhHU hchJI hJIhJIhJIhc hchc2C          $ % & ' gdi{gdJIgdcgdJIgdc gdcgdcgdc@ 00&P1:pcBP/ =!"#$%hh (s02&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH nH sH tH <`< sNormalKH_HmH sH tH ^^ s Heading 1$$@&!B*CJ OJPJQJ^JaJ ph.tDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List :o: #hGBase$a$_HmH sH tH 66 sChapter@&a$5;DD sDepartmentTitlea$5;6O26 %7History ^``6<O2< s HistoryAfter^64OB4 sItem^`02OR2 $s Paragraph@&4b4 sPart ^p`02O2 &uRule ^p`5;66 sSection@&a$5;DD s SubChapter 1$@&a$ 5;hFF s SubItem Lvl 1 ^p`0FF s SubItem Lvl 2 ^@ `0FF s SubItem Lvl 3x^`0FF s SubItem Lvl 4H^`0HH 's SubParagraph@&^`0:: sSubPart ^@ `0Z/Z sHeading 1 Char%B*CJ KHOJPJQJ^JaJ ph.t@@ s Subsubpart!x^`0D"D H4HistoryAuthority"a$6*1* N Base Char4/A4 NParagraph Char4/Q4 N History Char60/a0 N Rule Char5;:/q: NSubParagraph CharPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VvnB`2ǃ,!"E3p#9GQd; H xuv 0F[,F᚜K sO'3w #vfSVbsؠyX p5veuw 1z@ l,i!b I jZ2|9L$Z15xl.(zm${d:\@'23œln$^-@^i?D&|#td!6lġB"&63yy@t!HjpU*yeXry3~{s:FXI O5Y[Y!}S˪.7bd|n]671. tn/w/+[t6}PsںsL. J;̊iN $AI)t2 Lmx:(}\-i*xQCJuWl'QyI@ھ m2DBAR4 w¢naQ`ԲɁ W=0#xBdT/.3-F>bYL%׭˓KK 6HhfPQ=h)GBms]_Ԡ'CZѨys v@c])h7Jهic?FS.NP$ e&\Ӏ+I "'%QÕ@c![paAV.9Hd<ӮHVX*%A{Yr Aբ pxSL9":3U5U NC(p%u@;[d`4)]t#9M4W=P5*f̰lk<_X-C wT%Ժ}B% Y,] A̠&oʰŨ; \lc`|,bUvPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!R%theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] '3 #' '  #T # @H 0(  0(  B S  ?z/1{/1|/1}/18p(H}(8*urn:schemas-microsoft-com:office:smarttagsdate  1101983198822937DayMonthYear        (   #(   #(UAVjQ\l=:wr~n^`()^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`()^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.@ 0@ ^@ `0o(():wrUA jQ\l _v        e/        WN\{ aIZyuj ?hsxs= H^0evn7[*u2p} o 8 x"4#$^(,D2,[,rg,F-m-./K/Qh01L2D3PL3H45I5S96pu6}x6 7Y7 8g:8DQ}D^FhGXIIyJGMZ7M.OmSPRMkTwT,W%I\_KbBfcXdfpLg6h i "i{jM%k lemtp~r wi{L}_~a~e~-cN !6^JIV1D{:K+E%8v:>E"T?E6]' Vo,[.3%Fu3csa(UmEUby)JI<M8q^&~CR]e(~hM =tZ[$<tw,5V5S]~28r@FOwzAtU@'@UnknownG.Cx Times New Roman5Symbol3. *Cx ArialC.,*{$ Calibri LightA$BCambria Math"1h4G4Gss NP :c4 xx    Oh+'0L    ,4<DNormal1Microsoft Office Word@@   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q